Equinox Positioning
Equinox concentrates its activities on hit finding, hit-to-lead and lead (series) optimisation stages where substantial value can be created without the costs associated with pre-clinical or clinical development. We have already demonstrated superior performance in hit finding and as well as building upon this leadership position we will also concentrate upon demonstrating the value of the INDDExTM technology in hit to lead and lead optimisation.
The Equinox Pharma in-silico drug discovery pipeline. Our technologies target the key stages of Target Identification, Lead Validation, and Lead Optimisation to reduce the attrition rate of screening and time taken to reach clinical trials.
